Obstetric and Gynecologic Imaging

How Should You Monitor Monochorionic Twins? ACR-Guided Ultrasound Surveillance Workflow

·
How Should You Monitor Monochorionic Twins? ACR-Guided Ultrasound Surveillance Workflow

A 28-year-old G1P0 patient with a confirmed monochorionic-diamniotic twin pregnancy presents for her routine 20-week visit. The anatomy scan was grossly normal, but you know that the shared placenta puts this pregnancy at high risk for unique and serious complications. The immediate clinical question is not if she needs imaging, but what specific ultrasound protocol is required for ongoing surveillance. This isn’t a standard growth scan; it’s a targeted assessment to screen for conditions that can develop rapidly and require urgent intervention. For this specific scenario—antepartum growth and surveillance in monochorionic twins—the American College of Radiology (ACR) rates a comprehensive US assessment for TTTS as Usually appropriate, forming the cornerstone of management. This article details the clinical workflow for ordering and interpreting this critical surveillance.

Who Fits This Clinical Scenario for Monochorionic Twin Surveillance?

This guidance applies to patients with a confirmed monochorionic multiple gestation (either monochorionic-diamniotic or the rarer monochorionic-monoamniotic) who are undergoing routine antepartum surveillance. This typically begins around 16 weeks of gestation and continues every two weeks until delivery. The core assumption is that chorionicity was correctly established in the first trimester, and the current goal is active screening for the unique complications associated with a shared placenta in an otherwise structurally normal pregnancy.

This workflow is distinct from several related clinical situations. This article does not apply to:

  • First-trimester evaluation: The initial dating scan and determination of chorionicity and amnionicity fall under a different ACR variant. This workflow begins after monochorionicity is already established.
  • Dichorionic twin surveillance: Pregnancies with two separate placentas have a different risk profile and a less intensive surveillance schedule focused primarily on growth, not the specific syndromes detailed here. That scenario is covered separately in the ACR guidelines.
  • Evaluation of a known fetal abnormality: If a major structural anomaly, such as a cardiac defect, has already been diagnosed in one or both twins, the imaging protocol is tailored to that specific finding and may require additional studies beyond routine surveillance.

The focus here is on the proactive, scheduled screening essential for managing the inherent risks of a shared placental circulation.

What Complications Are You Screening for in Monochorionic Twins?

The intensive surveillance protocol for monochorionic twins is designed to detect a specific set of life-threatening conditions that arise from the vascular anastomoses within the shared placenta. The imaging workup is a screening process for this differential of potential complications.

Twin-Twin Transfusion Syndrome (TTTS) is the most feared and well-known complication. It results from unbalanced blood flow across arteriovenous anastomoses, leading to one twin (the “donor”) becoming volume-depleted and anemic, while the other twin (the “recipient”) becomes volume-overloaded and polycythemic. Clinically, this manifests on ultrasound as oligohydramnios in the donor’s sac and polyhydramnios in the recipient’s sac. Without intervention, severe TTTS is often fatal for both fetuses.

Selective Fetal Growth Restriction (sFGR) occurs due to unequal sharing of the placenta, where one twin receives a disproportionately small portion of the placental mass and, consequently, inadequate nutrition. This leads to significant growth discordance between the twins. While some growth difference is common, sFGR is a pathologic state that carries a high risk of poor outcomes for the smaller twin, particularly when associated with abnormal umbilical artery Doppler findings.

Twin Anemia Polycythemia Sequence (TAPS) is a more subtle form of chronic, unbalanced transfusion through minute placental anastomoses. Unlike TTTS, it does not typically involve major amniotic fluid discrepancies. Instead, it leads to severe anemia in the donor twin and polycythemia in the recipient. TAPS is diagnosed by measuring the peak systolic velocity (PSV) in the middle cerebral artery (MCA) of each fetus, which is a surrogate for fetal anemia or polycythemia.

Twin Reversed Arterial Perfusion (TRAP) Sequence is a rare and severe anomaly where one twin lacks a normally developed heart (acardiac twin) and is perfused in a retrograde fashion by the structurally normal “pump” twin via a large artery-to-artery anastomosis. This places an immense strain on the pump twin’s heart, leading to a high risk of cardiac failure and death. While often diagnosed in the first trimester, ongoing surveillance is critical to monitor the pump twin’s cardiac function.

Why Is a Specialized Ultrasound Assessment the Recommended Surveillance Method?

For the surveillance of monochorionic twins, a comprehensive ultrasound examination is the only modality capable of assessing the key physiologic and anatomic markers for the primary complications. The ACR designates several ultrasound components as Usually appropriate, which are typically performed together as part of a single, detailed examination often referred to as a “US assessment for TTTS.” This is not a simple growth scan; it is a multi-part hemodynamic and biometric evaluation.

The core components of this assessment include:

  • Biometry and Amniotic Fluid Assessment: A standard transabdominal ultrasound is used to measure fetal size (for estimated fetal weight and growth discordance) and the maximum vertical pocket (MVP) of amniotic fluid in each sac. These are the primary screening tools for sFGR and TTTS, respectively.
  • Umbilical Artery (UA) Doppler: This duplex Doppler study assesses placental function and resistance to blood flow. Abnormal UA Doppler findings (absent or reversed end-diastolic flow) in the smaller twin are a critical marker of severe placental insufficiency in sFGR and can influence the timing of delivery.
  • Middle Cerebral Artery (MCA) Doppler: This duplex Doppler measurement of the peak systolic velocity in the MCA is the essential screening tool for TAPS. An elevated MCA PSV suggests anemia (donor), while an abnormally low value suggests polycythemia (recipient).

All of these ultrasound-based studies are rated Usually appropriate because they directly and non-invasively assess the pathophysiology of the conditions being screened for. Critically, all ultrasound modalities carry a radiation level of 0 mSv, making them safe for repeated use every two weeks throughout the second and third trimesters.

Alternative studies are rated lower for this specific screening scenario. A fetal MRI without IV contrast is rated as May be appropriate, but it is not a primary surveillance tool. It is typically reserved for cases where a complex fetal anomaly is suspected and ultrasound is inconclusive. For routine screening, it provides no advantage over ultrasound and is less accessible. An MRI with IV contrast is Usually not appropriate due to the theoretical risks of gadolinium contrast crossing the placenta.

What’s Next After the Ultrasound? Downstream Workflow

The results of the bi-weekly surveillance ultrasound dictate the subsequent management, which can range from continued routine monitoring to urgent fetal intervention or delivery.

  • If the study is normal: If all parameters—growth, amniotic fluid volumes, and Dopplers—are within normal limits, the patient continues with the scheduled surveillance every two weeks. This reassuring result confirms that, at this point in time, no significant complication is present.
  • If the study is positive for TTTS: A diagnosis of TTTS (based on oligohydramnios/polyhydramnios criteria) is a critical finding. The patient should be referred immediately to a Maternal-Fetal Medicine (MFM) center with expertise in fetal therapy. Depending on the gestational age and severity (Quintero stage), the next step is often consideration for fetoscopic laser ablation of the placental anastomoses.
  • If the study suggests sFGR or TAPS: The management of sFGR depends on the type, based on umbilical artery Doppler findings. TAPS also requires MFM consultation for potential management options like in-utero transfusion or laser therapy. In both cases, surveillance frequency may be increased to weekly or even more often.
  • If the study is indeterminate: Ambiguous findings, such as borderline amniotic fluid or growth discordance that doesn’t meet strict criteria, warrant closer follow-up. The next step is typically to repeat the ultrasound in one week rather than two. A fetal echocardiogram (May be appropriate) may be ordered if there are concerns about cardiac function in either twin, particularly in the recipient twin in TTTS or the pump twin in TRAP sequence.

Pitfalls to Avoid (and When to Get Help)

Managing monochorionic twin pregnancies requires meticulous attention to the details of the surveillance protocol. Common pitfalls to avoid include:

  • Not starting surveillance early enough: Screening should begin at 16 weeks gestation, as TTTS can present early.
  • Extending the surveillance interval: The bi-weekly interval is evidence-based. Extending it to three or four weeks can miss the rapid onset of severe TTTS.
  • Ordering a generic “fetal growth” ultrasound: The order must specify a complete assessment for a monochorionic twin pregnancy, including amniotic fluid MVP for each sac and UA/MCA Dopplers for both fetuses. A standard biometry-only scan is insufficient.
  • Misinterpreting chorionicity: The entire high-risk management pathway depends on the correct initial determination of monochorionicity. If there is any doubt, an expert review of the first-trimester ultrasound is warranted.

If any signs of TTTS, severe sFGR with abnormal Dopplers, or TAPS are identified, this constitutes a clinical emergency requiring immediate consultation with a Maternal-Fetal Medicine specialist.

Related ACR Topics and Tools

The ACR Appropriateness Criteria provide comprehensive guidance on imaging for a wide range of clinical scenarios. For breadth across all scenarios in Multiple Gestations, see our parent guide: Multiple Gestations: ACR Appropriateness Decoded.

For additional decision support and technical details, the following GigHz resources are available:

Frequently Asked Questions

Why is surveillance for monochorionic twins performed every two weeks?

The bi-weekly interval is recommended by major obstetrical societies because critical complications like Twin-Twin Transfusion Syndrome (TTTS) can develop and progress very rapidly, sometimes in a matter of days. A two-week interval provides a balance between detecting the condition early enough for effective intervention and the logistical burden of more frequent scanning.

What is the difference between a standard growth ultrasound and a ‘US assessment for TTTS’?

A standard growth ultrasound primarily focuses on fetal biometry to estimate weight. An assessment for TTTS is much more comprehensive. In addition to biometry, it requires measurement of the maximum vertical pocket (MVP) of amniotic fluid in each sac, as well as Doppler assessment of the umbilical artery (UA) and middle cerebral artery (MCA) for both fetuses. These additional components are essential for screening for TTTS, TAPS, and sFGR.

If the twins are monochorionic-monoamniotic, does this surveillance protocol still apply?

Yes, but with additions. Monoamniotic twins share a single amniotic sac and have all the risks of monochorionic-diamniotic twins (TTTS, TAPS, sFGR) plus the additional significant risk of cord entanglement. Their surveillance protocol includes all the elements described here, but often involves even more frequent monitoring, including assessment of the umbilical cords, and typically requires inpatient admission for continuous fetal monitoring later in gestation.

Is a fetal MRI useful for routine surveillance of monochorionic twins?

No, for routine surveillance, fetal MRI is not the primary tool and is rated as ‘May be appropriate’ by the ACR. Its role is reserved for specific indications, such as clarifying a suspected complex fetal anomaly (like a brain or cardiac abnormality) that is not well-visualized on ultrasound. It does not replace the essential hemodynamic and fluid assessments provided by serial ultrasounds.

Can this intensive surveillance be stopped if everything looks normal at 30 weeks?

No, the risk of complications like TTTS and TAPS persists throughout the pregnancy. Surveillance must be continued at the recommended bi-weekly interval (or more frequently if indicated) until delivery. Late-onset TTTS and TAPS can still occur.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 29, 2026